top of page
  • Writer's pictureAdmin

Guam's breakthrough infection rate increases

Updated: Oct 6, 2021

By Pacific Island Times News Staff

Guam’s breakthrough infection rate has increased from 31 percent in August to 39 percent in September, data from the Department of Public Health and Social Service show.

Data obtained through a Freedom of Information Act request showed that Guam had a total of 3,519 Covid-19 positive cases throughout the month of September. Of this total 1,809, or 51.4 percent, were unvaccinated; 1,359 or 39 percent, were fully vaccinated; 304 or 8.6 percent were partially vaccinated; and 47 or 1.3 percent were unverified.

Complete statistics for breakthrough hospitalizations were not immediately available.

Daily reports from the Joint Information Center shows an average of 41 percent breakthrough hospitalizations

To date, there have been a total of 15,465 officially reported cases, 206 deaths, 2,223 cases in active isolation, and 13,038 not in active isolation. The CAR Score is 27.5.

Read related stories

The Centers for Disease Control and Prevention recently said mild cases of Covid-19 among vaccinated individuals are becoming increasingly common as the highly contagious delta variant barrels through communities.

CDC said this trend will continue in the coming months as the efficacy of the vaccine wanes after six months. But physicians and health authorities seek to allay the public's fear, saying the surge in breakthrough cases shouldn’t be a cause for significant concern.

The Kaiser Foundation last week released the result of a survey indicating that the American public "appears resigned to a future in which Covid-19 remains present in the U.S. and is managed much like the seasonal flu rather than one in which the disease is completely eliminated."

“It’s likely that everybody will probably get infected with Covid-19 [at some point] because it’s an endemic respiratory virus. The goal is to make sure that at that time, that infection occurs after you’ve been vaccinated so it’s mild,” said Amesh Adalja, a doctor and infectious disease specialist at Johns Hopkins Center for Health Security.

Subscribe to

our digital

monthly edition


bottom of page